4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-004501
General Counsel sold 2,573 shares at an average $5.09 ($13,101)
- General Counsel gave 98,346 shares (gift)
- General Counsel gave 98,346 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Edward General Counsel | 2022-12-02 | Gift | −98,346 | 151,031 | D: show line 1 in the form | ||
| Miller Edward General Counsel | 2022-12-02 | Gift | +98,346 | 288,799 | I: show line 2 in the form | ||
| Miller Edward General Counsel | 2023-01-19 | Sale | −2,032 | $5.08 | $10,318 | 148,999 | D: show line 3 in the form |
| Miller Edward General Counsel | 2023-01-20 | Sale | −541 | $5.14 | $2,783 | 148,458 | D: show line 4 in the form |
| Open-market sales · 2,573 sh · avg $5.09 · $13,101 | |||||||
Loading xslF345X03/doc4.xml…